Lemaitre Vascular (LMAT) EBITDA Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Lemaitre Vascular (LMAT) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168.00 |
| Mar 31, 2026 | 457.00 |
| Dec 31, 2025 | 380.00 |
| Sep 30, 2025 | 576.00 |
| Jun 30, 2025 | 553.00 |
| Mar 31, 2025 | 684.00 |
| Dec 31, 2024 | 674.00 |
| Sep 30, 2024 | 369.00 |
| Jun 30, 2024 | 569.00 |
| Mar 31, 2024 | 663.00 |
| Dec 31, 2023 | -446.00 |
| Sep 30, 2023 | 27.00 |
| Jun 30, 2023 | -2,385.00 |
| Mar 31, 2023 | -198.00 |
| Dec 31, 2022 | -716.00 |
| Sep 30, 2022 | -460.00 |
| Jun 30, 2022 | -776.00 |
| Mar 31, 2022 | 267.00 |
| Dec 31, 2021 | 423.00 |
| Sep 30, 2021 | 63.00 |